This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Orion Corporation. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Riina Arvela: Innovator in TRPA1 Modulation
Introduction
Riina Arvela is a prominent inventor based in Turku, Finland. She has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate TRPA1 activity. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Riina Arvela holds a patent for "N-prop-2-ynyl carboxamide derivatives and their use as TRPA1 antagonists." This patent describes compounds of formula I, wherein A, B, X, Z, and R-R are defined in the claims. These compounds exhibit TRPA1 activity and are thus useful as TRPA1 modulators. This invention highlights her commitment to exploring new therapeutic avenues.
Career Highlights
Arvela is currently associated with Orion Corporation, a leading pharmaceutical company in Finland. Her role at Orion Corporation allows her to collaborate with other experts in the field and contribute to groundbreaking research. With her innovative mindset, she continues to push the boundaries of what is possible in drug development.
Collaborations
Throughout her career, Riina has worked alongside talented colleagues, including Terhi Heikkinen and Patrik Holm. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of new therapeutic strategies.
Conclusion
Riina Arvela's contributions to the field of pharmacology, particularly through her patent on TRPA1 modulators, demonstrate her innovative spirit and commitment to advancing medical science. Her work at Orion Corporation and collaborations with esteemed colleagues further enhance her impact in the industry.